Regulatory T cell (Treg) therapy has potential for managing self-antigen reactive disorders (IMAGE)

Research

Regulatory T cell (Treg) therapy has potential for managing self-antigen reactive disorders

Caption

 In this study, researchers from China have identified that Egr-1 is a key regulatory gene that promotes the activity of Treg via Foxp3 activation, paving way towards the advancement of Treg therapies

Credit

Kim Hasenkrug, Dave Dorward and Austin Athman, Rocky Mountain Laboratories, NIAID, NIH from Wikimedia Commons

Usage Restrictions

Credit must be given to the creator.

License

CC BY

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.